•
Sep 30, 2014

Edwards Lifesciences Q3 2014 Earnings Report

Total Revenue
$607M
Previous year: $496M
+22.5%
EPS
$0.13
Previous year: $0.11
+18.2%
Gross Profit
$439M
Previous year: $366M
+20.1%
Cash and Equivalents
$404M
Previous year: $471M
-14.2%
Total Assets
$3.35B
Previous year: $2.53B
+32.4%

Edwards Lifesciences

Edwards Lifesciences